T

Tango Therapeutics
D

TNGX

27.955
USD
0.97
(3.58%)
قبل الجلسة·26.500USD-1.455(-5.20%)
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
227,817
الربح لكل سهم
-1
العائد الربحي
-
P/E
-33
حجم السوق
4,713,502,809
نظرة عامة
أصول ذات صلة
EPD
EPD
D
Enterprise Products Partners LP
36.515
-0.045(-0.12%)
ET
ET
D
Energy Transfer LP
20.060
-0.075(-0.37%)
20.140+0.080(+0.40%)
KMI
KMI
D
Kinder Morgan
33.708
-0.292(-0.86%)
34.350+0.642(+1.90%)
MPLX
MPLX
D
Mplx LP
58.160
-0.255(-0.44%)
OKE
OKE
D
Oneok
93.950
0.840(0.90%)
PBA
PBA
D
PEMBINA PIPELINE Corp
49.360
-1.317(-2.60%)
T
TGE
D
Generation Essentials Group (The)
0.78010
-0.07050(-8.29%)
WMB
WMB
D
Williams Companies
70.640
-2.165(-2.97%)
72.980+2.340(+3.31%)
المزيد

العنوان: Tango Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNScancers, including GBM. Its pipeline products are PRMT5 and CoREST.